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Mini-abstract 
Post-operative monitoring of pain and distress in small rodents is not standardized and widely 
accepted score sheets are not available. Here we describe a score sheet used in abdominal surgery of 
rodents, with particular reference to procedures on the liver. 
 
 
 
  
Introduction 
The world-wide use of animals for medical research has resulted in an enormous number of different 
“disease models” in a few select species, primarily rodents. The focus of these animal models is on 
the simulation of a particular disease, either through genetic manipulation, application of drugs or 
surgical manipulations. These manipulations can be a potential source of pain and suffering. The 
protection of animals used for scientific purposes is regulated by country specific laws, but the way 
these laws are implemented shows considerable variation between the countries. 
Despite the lack of standardized animal protection laws, the development and use of animal models 
should not only focus on the simulation of disease but also include an evaluation of proper pain 
management and surveillance. A lot of efforts have been invested in the past to develop reliable 
protocols for the assessment of pain and analgesic treatments of laboratory animals.  
Nevertheless, mainly due to the uncertainty regarding pain and stress detection and incongruences in the 
data obtained, no final protocols could be developed yet for appropriate and practicable monitoring and 
management of pain and suffering. 
Current efforts into improved behavioral monitoring and pain assessment clearly indicate a need for 
action. As an example, the use of the opioid buprenorphine  for post-operative analgesia is widely 
accepted.1 Although its half-life is longer than in other opioid-analgesics, it is less than four hours, 
requiring a tight and repetitive application every 4-6 hours by injection. It is obvious that the 
investigator doesn’t want to follow such a schedule as it would indicate an application of analgesia 
twice during the night. Also, repeated injections at short intervals may be stressful to the animals2-4. 
Alternatives are providing the drug through drinking water which requires a ten-fold higher amount of 
buprenorphine due to the consumption and to first-pass hepatic extraction of orally applied 
buprenorphine. Furthermore, there is also the possibility of spillage of drinking water with most current 
caging systems. In addition, it remains unclear, whether individual animals voluntarily consume 
sufficient amounts of the medicated water to ensure permanent pain alleviation, especially during the 
daylight phase, when mice do not drink regularly. Nevertheless, providing analgesia with drinking 
water has become popular, particularly for short half-life opioids (e.g. Tramadol) or NSAIDs (e.g. 
acetaminophen/paracetamol). 5Thus, long-lasting forms of analgesia are badly needed, however, 
sustained-release formulations of pain-killers are not commercially available to date in Europe, 
although those drugs have been developed for rodents, particularly buprenorphine which provides 1-3 
days continuous pain treatment 3, 6, 7.  
Non-steroidal anti-inflammatory drugs (NSAID, e.g., meloxicam, carprofen) are often administered in 
mice; some of them are injected only 1-2 times per day based on the assumption that they provide 
pain relief for up to one day.1 However current publications raise doubts about the analgesic efficacy 
of some NSAIDs. Particularly the efficacy of commonly used dosages and the suggested length of 
action remain unclear.8-10 One of the problems arising from provision of pain relieving drugs to 
experimental animals is that these can interfere with the experiment. For example, in studies 
evaluating nociception or the effect of pain on a disease model, treatment with an analgesic may forfeit 
the purpose of the experiment. Similarly, when studying inflammatory diseases, medication including 
analgesics, may affect the inflammatory process itself and hence partially interfere with the 
experimental goal.8 These examples indicate that an evaluation of efficient pain management is 
difficult and may require certain compromises.  
New indicators of pain are necessary to improve the quality of pain assessment. This is not simple to 
achieve and probably only the identification of behavioral traits can provide sufficient information 
during simple cage-side monitoring as performed when score sheets are used. For example, audible 
vocalizations cannot be unambiguously interpreted: are they due to real pain or distress? Recent 
studies, aimed at the identification of objective parameters for the assessment of pain, analyzed the 
link between behavioral changes and alterations in heart rate and heart rate variability using sensors 
implanted to continuously monitor physiological parameters. 11, 12 These experiments show good 
correlation of cardiovascular reactions with signs of pain and stress. Monitoring long-term 
physiological parameters and associated behaviors by continuous telemetric or video recordings 
(lasting for hours or days) provide evidence for pain only retrospectively. From a practical point of view 
such sensors cannot be implanted into each and every experimental animal, first because this would 
involve additional unnecessary stress and would undoubtedly be painful for some time after surgical 
implantation of the transmitter, but also because not all experimental situation would allow such a 
sophisticated operation e.g. in very young animals. Additionally, observation of alterations of specific 
spontaneous home-cage behavior such as burrowing and nest-building recently have been 
established not only as signs of disturbed wellbeing 13 or to monitor the progression of 
neurodegenerative diseases 14-16 but also for the detection of post-operative pain but may be time 
consuming 16, 17 Thus short cage-side observations taken immediately after the painful insult have 
been used for many years and allow the immediate treatment of pain. In practical terms, individuals 
are monitored for approximately 10 minutes either in the home cage or an observation area for 
very short-term aberrations of bodily appearance, that are known to be indicative for specific 
types of pain, e.g., press, stagger, stretch, twitch are thought to be typical signs of abdominal pain 
in mice18 Such very specific symptoms are often combined to composite scales, summarizing the 
most frequent and indicative alterations 19 However, a well-known drawback of such cage-side 
observations is, that occurrence of aberrations provides some evidence for pain but absence of 
these during the short observation period does not prove that animals are pain-free.   
Another approach to assess pain is the grimace scale: facial changes and contortions indicate pain 20. 
This approach, although plausible, requires videotaping of individual animals and and its use during 
routine monitoring is not yet validated.  
The assessment requires adaptation to the experimental condition, animal strain, sex etc. and the observer 
needs  training and experience to recognize and categorize facial features 21. 
 
Thus, methods reliably indicating pain are quite complicated needing intensive analysis of individual 
animals and additional technical devices. Behavioral science has implemented quantitative 
approaches, based on statistical analysis of animal cohorts. Assessment of individual animals, 
however, is more subjective and may be biased due to the investigators wish to continue without 
interfering with the experiment. Hence, implementation of robust surveillance protocols, which are 
quantitative, reproducible and allow longitudinal follow-up, are needed. Many investigators have 
established their own ‘score’ sheet based on the requirements of the local animal ethics committee. 
These score sheets are usually not included or detailed in publications. Here we propose a score 
sheet for post-operative surveillance that includes a quantitative approach with cut-offs defining 
termination of the experiment and euthanasia of the animal in case of unacceptable suffering. We are 
well aware that this sheet is not exclusively based on scientific evidence but also on experience with 
several decades of animal experiments. The score sheet has been developed along with animal 
welfare officers and authorities in charge of ordinances for animal experimentation. 
 
Animal models in abdominal surgery 
Surgical modification of organs in the abdominal cavity include operations on the liver e.g. partial liver 
resection (see in 22), liver transplantation23, bile duct ligation24. Partial or full splenectomies, kidney 
transplantation25, induction of strictures in the intestine, pancreatectomies26, pancreatic duct ligation27 
etc. are other examples of intra-abdominal interventions.  These models have one thing in common: 
access to the abdominal cavity is by a laparotomy (incision through the abdomen). The post-operative 
time frame of these experiments can be between a few hours and several months, whereby pain is 
experienced in the first two-three days. 
The most used procedure (e.g., partial hepatectomy) consists usually of a preoperative injection i.p. of 
buprenorphine (0.1 mg/kg body weight), approximately 30 minutes before the operation. 
Subsequently, animals are shaved and immobilized under inhalation anesthesia using isoflurane. The 
animals are fixed by tape on a stainless steel plate in a supine position. The plate is warmed by a 
heating pad, maintaining 37-40°C. Eye ointment is applied and the abdomen is opened by a sagittal 
incision after disinfection with alcohol. To access the liver, the sternum may be pulled upwards and 
fixed by a 6-0 suture. The liver ligaments are then freed followed by individual ligation of vessels to 
liver lobes, which can then be dissected. After completion, the abdomen is then closed by a running 
suture of the peritoneal muscle/fascia followed by closing the skin. For recuperation, the animal is 
placed in a warming cabinet (28-30°C) for a few hours or overnight, prior to its return to the regular 
cage. 
 
As in human surgery, the impact of the specific type of intervention (e.g. partial hepatectomy) may be 
moderate to severe and thus the access to the abdomen i.e. the laparotomy itself may have a variable 
impact on the overall procedure. Furthermore, a lot of procedures in human patients can be performed 
by laparoscopy (minimal invasive), which strongly reduces postoperative morbidity. Although minimal 
invasive approaches have been tested in rodents, routine use is not feasible. 
In the current report, we focus predominantly on experiments concerning liver surgery. A classic 
example is a 70% resection of liver lobes22. This procedure is fairly standardized and benefits from the 
anatomy of the mouse or rat liver which are quite lobulated. Therefore, parenchymal transections are 
not required because the lobes can be individually removed by ligation of the vessels. This procedure 
is well tolerated. The liver usually regains its original size within a week. In addition, extended 
hepatectomies e.g. 86% and 91% removal of liver tissue, have been established to explore the effects 
of an insufficient liver volume28. This situation can lead to a so-called small-for-size syndrome: the 
small liver is not able to regenerate, most probably due to the metabolic overload and concurrent 
accumulation of toxic products29.  
The small-for-size syndrome, particularly with a full blown liver failure, results in reduced activity, 
apathy and encephalopathy (‘hepatic coma’). Pain assessment of these animals has been debated, as 
reports from patients with similar syndrome do not complain of pain. In addition, analgesia may further 
impact on hepatic function and is given with caution. 
Assessment of welfare 
Usually, pain is assessed by the investigator who observes the animals for a short period of time 
looking predominantly at active behavior, ruffling of the fur and hunchback position. When there are 
several animals in a cage an individual repeated assessment over time is inaccurate. Once an animal 
is identified that is clearly in pain, it should be treated properly by analgesics. This leads to the 
question, should all animals in the experiment receive the same treatment to ensure consistency? 
Would it be better to treat all animals from the start with analgesic to avoid having to change the 
experimental protocol based on an individual animal? Alternatively, if a single animal shows abnormal 
behavior and pain, it might be better to eliminate the animal from the experiment. These are questions 
that should be clarified before beginning an experiment, particularly if the animals are valuable due to 
complex genetics or require special treatment e.g. diabetic mice receiving insulin. 
 
Below we describe a score sheet used for monitoring after abdominal operations, particularly on the 
liver. 
Post-operative score sheet 
For each animal undergoing abdominal surgery, a score sheet is prepared, indicating animal ID, 
protocol ID, date and prospective severity degree (CH 0-III). Also the type of intervention should be 
indicated. This basic information will allow a replacement investigator take over surveillance, 
particularly if an animal caretaker or veterinarian has reported an animal ill. 
Depending on the protocol, the severity or expected health issue, the investigator may be asked to 
supervise the animals very closely i.e. twice a day. For proper observation, it is advised to take each 
animal out of its cage, place it on top of the grid or lid as deemed best for observation of the animal. If 
there are only one or two animals per cage, observation may be performed without touching the 
animals, however, animals must be freely visible.  Overall, a solid knowledge of normal behavior and 
appearance of a mouse of the respective line, sex and age is prerequisite for proper monitoring. 
Activity 
In the following, scored behaviors and signs of distress are described. Activity may be judged taking 
into account the time of day, which affects the diurnal activity pattern. Absence of activity is certainly an 
indicator of an impaired condition and health. However, normal or even increased activity is not necessarily 
an indicator for the absence of pain or suffering and it is mandatory to observe other parameters or 
symptoms to assess the picture. Aggressive animals may appear very active and aggression is a potential 
indicator of pain. Reduced activity is given one point while immobility is a strong factor and should be given 
three points. Increased activity is very subjective and might be induced by buprenorphine treatment3 and 
therefore does not get any points in our score sheet. .. 
Breathing 
Breathing rate and depth are not easy to assess in mice without specialized equipment. However, 
animals with flat breathing but normal frequency are given one point, while shallow, rapid breathing is 
an indicator for more severe physical impairment (two points). 
Fur  
The appearance of fur (piloerection, ruffling) is perhaps the easiest parameter to judge. Ruffled, 
unclean or matted fur indicates absence of normal grooming behavior. This is either based on physical 
impairment (through the experiment) or a stress situation in the cage, particularly, if several males 
share a cage. In this case, presence of bites, wounds or aggressive behavior may indicate social 
imbalance. Such an imbalance can be prompted if one or two animals of the cohort are operated on 
and maybe weakened, resulting in a change of the social hierarchy. It is therefore recommended that 
operated animals should not be mixed with untreated, healthy litter mates for the time of recovery, i.e. 
during the first one to maximally four post-operative days only operated animals are kept together. 
Ruffled fur receives one point. 
Posture 
Another, quite easy parameter is the posture, such as hunchback or arching behavior. This is 
observed when the animals are in strong abdominal pain and is found in combination with ruffled fur. 
Contradictory reports are present on the interpretation of hunched posture in mice18, 30-33, and it was 
recently described not to be a reliable indicator of pain18, 33. Based on our previous results on 
laparotomy11 we assign one point for hunchback or arching behavior.  
Jaundice 
Jaundice indicates loss of liver function and may be due to a direct interference with the liver by 
surgery or pharmacological treatments targeting the liver. It appears as a yellowing of the skin. In case 
of mice with black or dark fur, the eyes or the footpads easily allow an assessment. If jaundice is part 
of the pathophysiology of the model, bilirubin should be measured regularly by blood analysis. If 
another organ is targeted, blood parameters can be assessed: creatinine for kidney, amylase for 
pancreas, T3/4 for thyroid etc. This parameter receives one point. 
Operative site: Assessment of the wound 
Wound infections are rare in rodents. In contrast to humans and larger animal species, particularly 
pets, the wound cannot be covered by a wound dressing. It is therefore crucial that the wound be 
properly closed to avoid entry of foreign material, or worse, extrusion of an intestinal loop. For proper 
postoperative examination, particularly in the first two days, mice have to be removed from the cage 
and individually inspected.  
Particularly when pain medication is insufficient mice tend to bite and gnaw at their wounds, further 
enhancing chances for infection. However, overdosing with buprenorphine might also lead to aberrant 
behavior where the animals mutilate the wound (e.g. removal of sutures).   
An open or infected wound receives two points. Additional criteria specific to the experiment can be 
introduced and scored. 
Overall score 
At conclusion of an assessment, points should be added up. A mouse having two or more points 
should receive pain treatment. In the case of five points, a critical physical impairment has been 
reached which should receive particular attention. Adequate pain management should be provided in 
both cases, i.e., a protocol (giving detailed advice on drug, dosage, administration route and interval) 
must be in place, which has been developed and tailored regarding the model (e.g., interference with 
experimental goals) and type of pain. Typically, we administer a bolus injection of buprenorphine (0.1 
mg/kg s.c.) two or three times a day. If no improvement is observed within the next 24 hours, the 
animal should be euthanized. Below is a summary of the criteria leading to termination. Some are 
independent criteria e.g. cachexia (short and long term weight loss) or if the animal is self-mutilated.  
 
Summary of termination criteria: 
 
- the animal does not recuperate from the intervention (immobile, unresponsive to stimuli 2 hrs 
after the operation) 
- score ≥6 points.  
- Score = 5 points: plus no improvement within the next 24 hrs  
- the animal loses >15% of body weight within 12 hours after operation (short term weight loss) 
- the animal loses >20% of body weight compared to start of experiment (long term weight loss)  
- animal is self-mutilated 
- animal exhibits signs of pain despite buprenorphin treatment for three days. 
- animal does not respond to pain treatment within 24 hrs   
 
Refinement opportunities 
Through an invasive procedure of the abdominal cavity, an animal is transiently incapacitated and may 
lose its social status. It is imperative that the animal has opportunity to create a refuge in the form of 
nest building or burrowing material or shelters. Particularly in male animals, short-term isolation during 
intervention, and physical impairment may severely disturb the social structure. It should be evaluated 
whether a single individual should be placed back in the cage with its healthy littermates. Presumably, 
if all animals in a cage are operated at the same time, the individual will suffer less from the possibly 
disrupted social structure or may even profit from social support3. 
 
Recommendation and Further 3Rs research 
Historically, surgeons preferred to operate on male mice. With their tendency to aggressive behavior, 
increasing with age, female mice might be more amenable. In particular, studies addressing age-
related topics would greatly benefit from the inclusion of female mice. The social structure of the rat is 
different and males are less aggressive. Here, the need to focus on one sex is not as crucial.  
In both species, it might be advisable in the future to use both genders. First, to exclude conclusions 
that may or may not apply to both sexes, and second, the use of all animals reduces the overall 
number of animals to be produced. Currently, a vast number of animals are still killed since the 
demand for one sex is much bigger for certain animal models. 
 
Conclusion 
Proper animal surveillance in routine settings is only possible if the process is easy and quick. 
Otherwise the likelihood that investigators will not seriously assess the wellbeing of their animals’ 
increases. This is to the detriment of the animal. It may ultimately affect the experimental outcome 
negatively and prevent relevant conclusions. The lack of diligence may also be a result of mice or rats 
observed to ‘happily’ and actively run around the cage. Such activity may imply that these animals are 
not in pain. This misconception is still commonly observed in many investigators and should be 
rectified by education and training.  
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